0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Discovery Assays Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-9K6167
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and United States Drug Discovery Assays Market Report Forecast 2022 2028
BUY CHAPTERS

Global Drug Discovery Assays Market Research Report 2025

Code: QYRE-Auto-9K6167
Report
July 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Discovery Assays Market Size

The global market for Drug Discovery Assays was valued at US$ 8395 million in the year 2024 and is projected to reach a revised size of US$ 15030 million by 2031, growing at a CAGR of 8.8% during the forecast period.

Drug Discovery Assays Market

Drug Discovery Assays Market

The Drug Discovery Assays market is a fundamental and dynamic sector within the pharmaceutical and biotechnology industry, offering a wide array of techniques and tools to identify and validate potential drug candidates. These assays encompass various approaches, such as high-throughput screening, cell-based assays, biochemical assays, and target-based assays, which are vital in the drug discovery process, from target identification to lead optimization. They are known for their ability to provide critical insights into the pharmacological and toxicological properties of compounds, facilitating the development of novel drugs and therapies. The market is characterized by ongoing technological advancements, automation, and the integration of artificial intelligence and machine learning to enhance the efficiency and accuracy of drug discovery processes. Leading providers in the life sciences and biotechnology sector, including PerkinElmer, Thermo Fisher Scientific, and Promega Corporation, focus on delivering innovative assay technologies and platforms that cater to the evolving needs of pharmaceutical companies and research institutions. As the pharmaceutical industry continues to advance toward personalized medicine, precision therapeutics, and the development of treatments for various diseases, the Drug Discovery Assays market is poised for sustained growth, offering indispensable tools for accelerating drug discovery, improving drug safety, and enhancing the efficiency of bringing new medications to market.
This report aims to provide a comprehensive presentation of the global market for Drug Discovery Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery Assays.
The Drug Discovery Assays market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Discovery Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Discovery Assays companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drug Discovery Assays Market Report

Report Metric Details
Report Name Drug Discovery Assays Market
Accounted market size in year US$ 8395 million
Forecasted market size in 2031 US$ 15030 million
CAGR 8.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Danaher, Becton Dickinson, GE Healthcare, Merck, Lonza, PerkinElmer, Inc., Charles River Laboratories, Inc., Cell Signaling Technologies, Cisbio, Cell Biolabs, Inc., Promega, Pfizer, GSK, Agilent, Eli Lilly and Company, Roche, Bayer, Abbott, AstraZeneca, Shimadzu
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Drug Discovery Assays company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drug Discovery Assays Market growing?

Ans: The Drug Discovery Assays Market witnessing a CAGR of 8.8% during the forecast period 2025-2031.

What is the Drug Discovery Assays Market size in 2031?

Ans: The Drug Discovery Assays Market size in 2031 will be US$ 15030 million.

Who are the main players in the Drug Discovery Assays Market report?

Ans: The main players in the Drug Discovery Assays Market are Thermo Fisher Scientific, Danaher, Becton Dickinson, GE Healthcare, Merck, Lonza, PerkinElmer, Inc., Charles River Laboratories, Inc., Cell Signaling Technologies, Cisbio, Cell Biolabs, Inc., Promega, Pfizer, GSK, Agilent, Eli Lilly and Company, Roche, Bayer, Abbott, AstraZeneca, Shimadzu

What are the Application segmentation covered in the Drug Discovery Assays Market report?

Ans: The Applications covered in the Drug Discovery Assays Market report are Pharmaceutical and Biotechnology Companies, Academic and Government Institutions, Contract Research Organizations, Others

What are the Type segmentation covered in the Drug Discovery Assays Market report?

Ans: The Types covered in the Drug Discovery Assays Market report are Consumables, Instruments, Services, Software

Recommended Reports

Drug Screening & Testing

Drug Discovery Platforms

Diagnostic & Assay Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Discovery Assays Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Consumables
1.2.3 Instruments
1.2.4 Services
1.2.5 Software
1.3 Market by Application
1.3.1 Global Drug Discovery Assays Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic and Government Institutions
1.3.4 Contract Research Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery Assays Market Perspective (2020-2031)
2.2 Global Drug Discovery Assays Growth Trends by Region
2.2.1 Global Drug Discovery Assays Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Discovery Assays Historic Market Size by Region (2020-2025)
2.2.3 Drug Discovery Assays Forecasted Market Size by Region (2026-2031)
2.3 Drug Discovery Assays Market Dynamics
2.3.1 Drug Discovery Assays Industry Trends
2.3.2 Drug Discovery Assays Market Drivers
2.3.3 Drug Discovery Assays Market Challenges
2.3.4 Drug Discovery Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Discovery Assays Players by Revenue
3.1.1 Global Top Drug Discovery Assays Players by Revenue (2020-2025)
3.1.2 Global Drug Discovery Assays Revenue Market Share by Players (2020-2025)
3.2 Global Drug Discovery Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Discovery Assays Revenue
3.4 Global Drug Discovery Assays Market Concentration Ratio
3.4.1 Global Drug Discovery Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery Assays Revenue in 2024
3.5 Global Key Players of Drug Discovery Assays Head office and Area Served
3.6 Global Key Players of Drug Discovery Assays, Product and Application
3.7 Global Key Players of Drug Discovery Assays, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Discovery Assays Breakdown Data by Type
4.1 Global Drug Discovery Assays Historic Market Size by Type (2020-2025)
4.2 Global Drug Discovery Assays Forecasted Market Size by Type (2026-2031)
5 Drug Discovery Assays Breakdown Data by Application
5.1 Global Drug Discovery Assays Historic Market Size by Application (2020-2025)
5.2 Global Drug Discovery Assays Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Discovery Assays Market Size (2020-2031)
6.2 North America Drug Discovery Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Discovery Assays Market Size by Country (2020-2025)
6.4 North America Drug Discovery Assays Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Discovery Assays Market Size (2020-2031)
7.2 Europe Drug Discovery Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Discovery Assays Market Size by Country (2020-2025)
7.4 Europe Drug Discovery Assays Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery Assays Market Size (2020-2031)
8.2 Asia-Pacific Drug Discovery Assays Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Discovery Assays Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Discovery Assays Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Discovery Assays Market Size (2020-2031)
9.2 Latin America Drug Discovery Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Discovery Assays Market Size by Country (2020-2025)
9.4 Latin America Drug Discovery Assays Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery Assays Market Size (2020-2031)
10.2 Middle East & Africa Drug Discovery Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Discovery Assays Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Discovery Assays Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Drug Discovery Assays Introduction
11.1.4 Thermo Fisher Scientific Revenue in Drug Discovery Assays Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Danaher
11.2.1 Danaher Company Details
11.2.2 Danaher Business Overview
11.2.3 Danaher Drug Discovery Assays Introduction
11.2.4 Danaher Revenue in Drug Discovery Assays Business (2020-2025)
11.2.5 Danaher Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Details
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Drug Discovery Assays Introduction
11.3.4 Becton Dickinson Revenue in Drug Discovery Assays Business (2020-2025)
11.3.5 Becton Dickinson Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Details
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Drug Discovery Assays Introduction
11.4.4 GE Healthcare Revenue in Drug Discovery Assays Business (2020-2025)
11.4.5 GE Healthcare Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Drug Discovery Assays Introduction
11.5.4 Merck Revenue in Drug Discovery Assays Business (2020-2025)
11.5.5 Merck Recent Development
11.6 Lonza
11.6.1 Lonza Company Details
11.6.2 Lonza Business Overview
11.6.3 Lonza Drug Discovery Assays Introduction
11.6.4 Lonza Revenue in Drug Discovery Assays Business (2020-2025)
11.6.5 Lonza Recent Development
11.7 PerkinElmer, Inc.
11.7.1 PerkinElmer, Inc. Company Details
11.7.2 PerkinElmer, Inc. Business Overview
11.7.3 PerkinElmer, Inc. Drug Discovery Assays Introduction
11.7.4 PerkinElmer, Inc. Revenue in Drug Discovery Assays Business (2020-2025)
11.7.5 PerkinElmer, Inc. Recent Development
11.8 Charles River Laboratories, Inc.
11.8.1 Charles River Laboratories, Inc. Company Details
11.8.2 Charles River Laboratories, Inc. Business Overview
11.8.3 Charles River Laboratories, Inc. Drug Discovery Assays Introduction
11.8.4 Charles River Laboratories, Inc. Revenue in Drug Discovery Assays Business (2020-2025)
11.8.5 Charles River Laboratories, Inc. Recent Development
11.9 Cell Signaling Technologies
11.9.1 Cell Signaling Technologies Company Details
11.9.2 Cell Signaling Technologies Business Overview
11.9.3 Cell Signaling Technologies Drug Discovery Assays Introduction
11.9.4 Cell Signaling Technologies Revenue in Drug Discovery Assays Business (2020-2025)
11.9.5 Cell Signaling Technologies Recent Development
11.10 Cisbio
11.10.1 Cisbio Company Details
11.10.2 Cisbio Business Overview
11.10.3 Cisbio Drug Discovery Assays Introduction
11.10.4 Cisbio Revenue in Drug Discovery Assays Business (2020-2025)
11.10.5 Cisbio Recent Development
11.11 Cell Biolabs, Inc.
11.11.1 Cell Biolabs, Inc. Company Details
11.11.2 Cell Biolabs, Inc. Business Overview
11.11.3 Cell Biolabs, Inc. Drug Discovery Assays Introduction
11.11.4 Cell Biolabs, Inc. Revenue in Drug Discovery Assays Business (2020-2025)
11.11.5 Cell Biolabs, Inc. Recent Development
11.12 Promega
11.12.1 Promega Company Details
11.12.2 Promega Business Overview
11.12.3 Promega Drug Discovery Assays Introduction
11.12.4 Promega Revenue in Drug Discovery Assays Business (2020-2025)
11.12.5 Promega Recent Development
11.13 Pfizer
11.13.1 Pfizer Company Details
11.13.2 Pfizer Business Overview
11.13.3 Pfizer Drug Discovery Assays Introduction
11.13.4 Pfizer Revenue in Drug Discovery Assays Business (2020-2025)
11.13.5 Pfizer Recent Development
11.14 GSK
11.14.1 GSK Company Details
11.14.2 GSK Business Overview
11.14.3 GSK Drug Discovery Assays Introduction
11.14.4 GSK Revenue in Drug Discovery Assays Business (2020-2025)
11.14.5 GSK Recent Development
11.15 Agilent
11.15.1 Agilent Company Details
11.15.2 Agilent Business Overview
11.15.3 Agilent Drug Discovery Assays Introduction
11.15.4 Agilent Revenue in Drug Discovery Assays Business (2020-2025)
11.15.5 Agilent Recent Development
11.16 Eli Lilly and Company
11.16.1 Eli Lilly and Company Company Details
11.16.2 Eli Lilly and Company Business Overview
11.16.3 Eli Lilly and Company Drug Discovery Assays Introduction
11.16.4 Eli Lilly and Company Revenue in Drug Discovery Assays Business (2020-2025)
11.16.5 Eli Lilly and Company Recent Development
11.17 Roche
11.17.1 Roche Company Details
11.17.2 Roche Business Overview
11.17.3 Roche Drug Discovery Assays Introduction
11.17.4 Roche Revenue in Drug Discovery Assays Business (2020-2025)
11.17.5 Roche Recent Development
11.18 Bayer
11.18.1 Bayer Company Details
11.18.2 Bayer Business Overview
11.18.3 Bayer Drug Discovery Assays Introduction
11.18.4 Bayer Revenue in Drug Discovery Assays Business (2020-2025)
11.18.5 Bayer Recent Development
11.19 Abbott
11.19.1 Abbott Company Details
11.19.2 Abbott Business Overview
11.19.3 Abbott Drug Discovery Assays Introduction
11.19.4 Abbott Revenue in Drug Discovery Assays Business (2020-2025)
11.19.5 Abbott Recent Development
11.20 AstraZeneca
11.20.1 AstraZeneca Company Details
11.20.2 AstraZeneca Business Overview
11.20.3 AstraZeneca Drug Discovery Assays Introduction
11.20.4 AstraZeneca Revenue in Drug Discovery Assays Business (2020-2025)
11.20.5 AstraZeneca Recent Development
11.21 Shimadzu
11.21.1 Shimadzu Company Details
11.21.2 Shimadzu Business Overview
11.21.3 Shimadzu Drug Discovery Assays Introduction
11.21.4 Shimadzu Revenue in Drug Discovery Assays Business (2020-2025)
11.21.5 Shimadzu Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Drug Discovery Assays Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Consumables
 Table 3. Key Players of Instruments
 Table 4. Key Players of Services
 Table 5. Key Players of Software
 Table 6. Global Drug Discovery Assays Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Drug Discovery Assays Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Drug Discovery Assays Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Drug Discovery Assays Market Share by Region (2020-2025)
 Table 10. Global Drug Discovery Assays Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Drug Discovery Assays Market Share by Region (2026-2031)
 Table 12. Drug Discovery Assays Market Trends
 Table 13. Drug Discovery Assays Market Drivers
 Table 14. Drug Discovery Assays Market Challenges
 Table 15. Drug Discovery Assays Market Restraints
 Table 16. Global Drug Discovery Assays Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Drug Discovery Assays Market Share by Players (2020-2025)
 Table 18. Global Top Drug Discovery Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery Assays as of 2024)
 Table 19. Ranking of Global Top Drug Discovery Assays Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Drug Discovery Assays Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Drug Discovery Assays, Headquarters and Area Served
 Table 22. Global Key Players of Drug Discovery Assays, Product and Application
 Table 23. Global Key Players of Drug Discovery Assays, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Drug Discovery Assays Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Drug Discovery Assays Revenue Market Share by Type (2020-2025)
 Table 27. Global Drug Discovery Assays Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Drug Discovery Assays Revenue Market Share by Type (2026-2031)
 Table 29. Global Drug Discovery Assays Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Drug Discovery Assays Revenue Market Share by Application (2020-2025)
 Table 31. Global Drug Discovery Assays Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Drug Discovery Assays Revenue Market Share by Application (2026-2031)
 Table 33. North America Drug Discovery Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Drug Discovery Assays Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Drug Discovery Assays Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Drug Discovery Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Drug Discovery Assays Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Drug Discovery Assays Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Drug Discovery Assays Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Drug Discovery Assays Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Drug Discovery Assays Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Drug Discovery Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Drug Discovery Assays Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Drug Discovery Assays Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Drug Discovery Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Drug Discovery Assays Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Drug Discovery Assays Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Thermo Fisher Scientific Company Details
 Table 49. Thermo Fisher Scientific Business Overview
 Table 50. Thermo Fisher Scientific Drug Discovery Assays Product
 Table 51. Thermo Fisher Scientific Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 52. Thermo Fisher Scientific Recent Development
 Table 53. Danaher Company Details
 Table 54. Danaher Business Overview
 Table 55. Danaher Drug Discovery Assays Product
 Table 56. Danaher Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 57. Danaher Recent Development
 Table 58. Becton Dickinson Company Details
 Table 59. Becton Dickinson Business Overview
 Table 60. Becton Dickinson Drug Discovery Assays Product
 Table 61. Becton Dickinson Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 62. Becton Dickinson Recent Development
 Table 63. GE Healthcare Company Details
 Table 64. GE Healthcare Business Overview
 Table 65. GE Healthcare Drug Discovery Assays Product
 Table 66. GE Healthcare Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 67. GE Healthcare Recent Development
 Table 68. Merck Company Details
 Table 69. Merck Business Overview
 Table 70. Merck Drug Discovery Assays Product
 Table 71. Merck Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 72. Merck Recent Development
 Table 73. Lonza Company Details
 Table 74. Lonza Business Overview
 Table 75. Lonza Drug Discovery Assays Product
 Table 76. Lonza Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 77. Lonza Recent Development
 Table 78. PerkinElmer, Inc. Company Details
 Table 79. PerkinElmer, Inc. Business Overview
 Table 80. PerkinElmer, Inc. Drug Discovery Assays Product
 Table 81. PerkinElmer, Inc. Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 82. PerkinElmer, Inc. Recent Development
 Table 83. Charles River Laboratories, Inc. Company Details
 Table 84. Charles River Laboratories, Inc. Business Overview
 Table 85. Charles River Laboratories, Inc. Drug Discovery Assays Product
 Table 86. Charles River Laboratories, Inc. Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 87. Charles River Laboratories, Inc. Recent Development
 Table 88. Cell Signaling Technologies Company Details
 Table 89. Cell Signaling Technologies Business Overview
 Table 90. Cell Signaling Technologies Drug Discovery Assays Product
 Table 91. Cell Signaling Technologies Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 92. Cell Signaling Technologies Recent Development
 Table 93. Cisbio Company Details
 Table 94. Cisbio Business Overview
 Table 95. Cisbio Drug Discovery Assays Product
 Table 96. Cisbio Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 97. Cisbio Recent Development
 Table 98. Cell Biolabs, Inc. Company Details
 Table 99. Cell Biolabs, Inc. Business Overview
 Table 100. Cell Biolabs, Inc. Drug Discovery Assays Product
 Table 101. Cell Biolabs, Inc. Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 102. Cell Biolabs, Inc. Recent Development
 Table 103. Promega Company Details
 Table 104. Promega Business Overview
 Table 105. Promega Drug Discovery Assays Product
 Table 106. Promega Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 107. Promega Recent Development
 Table 108. Pfizer Company Details
 Table 109. Pfizer Business Overview
 Table 110. Pfizer Drug Discovery Assays Product
 Table 111. Pfizer Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 112. Pfizer Recent Development
 Table 113. GSK Company Details
 Table 114. GSK Business Overview
 Table 115. GSK Drug Discovery Assays Product
 Table 116. GSK Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 117. GSK Recent Development
 Table 118. Agilent Company Details
 Table 119. Agilent Business Overview
 Table 120. Agilent Drug Discovery Assays Product
 Table 121. Agilent Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 122. Agilent Recent Development
 Table 123. Eli Lilly and Company Company Details
 Table 124. Eli Lilly and Company Business Overview
 Table 125. Eli Lilly and Company Drug Discovery Assays Product
 Table 126. Eli Lilly and Company Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 127. Eli Lilly and Company Recent Development
 Table 128. Roche Company Details
 Table 129. Roche Business Overview
 Table 130. Roche Drug Discovery Assays Product
 Table 131. Roche Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 132. Roche Recent Development
 Table 133. Bayer Company Details
 Table 134. Bayer Business Overview
 Table 135. Bayer Drug Discovery Assays Product
 Table 136. Bayer Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 137. Bayer Recent Development
 Table 138. Abbott Company Details
 Table 139. Abbott Business Overview
 Table 140. Abbott Drug Discovery Assays Product
 Table 141. Abbott Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 142. Abbott Recent Development
 Table 143. AstraZeneca Company Details
 Table 144. AstraZeneca Business Overview
 Table 145. AstraZeneca Drug Discovery Assays Product
 Table 146. AstraZeneca Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 147. AstraZeneca Recent Development
 Table 148. Shimadzu Company Details
 Table 149. Shimadzu Business Overview
 Table 150. Shimadzu Drug Discovery Assays Product
 Table 151. Shimadzu Revenue in Drug Discovery Assays Business (2020-2025) & (US$ Million)
 Table 152. Shimadzu Recent Development
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Drug Discovery Assays Picture
 Figure 2. Global Drug Discovery Assays Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug Discovery Assays Market Share by Type: 2024 VS 2031
 Figure 4. Consumables Features
 Figure 5. Instruments Features
 Figure 6. Services Features
 Figure 7. Software Features
 Figure 8. Global Drug Discovery Assays Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Drug Discovery Assays Market Share by Application: 2024 VS 2031
 Figure 10. Pharmaceutical and Biotechnology Companies Case Studies
 Figure 11. Academic and Government Institutions Case Studies
 Figure 12. Contract Research Organizations Case Studies
 Figure 13. Others Case Studies
 Figure 14. Drug Discovery Assays Report Years Considered
 Figure 15. Global Drug Discovery Assays Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Drug Discovery Assays Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Drug Discovery Assays Market Share by Region: 2024 VS 2031
 Figure 18. Global Drug Discovery Assays Market Share by Players in 2024
 Figure 19. Global Top Drug Discovery Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery Assays as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Drug Discovery Assays Revenue in 2024
 Figure 21. North America Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Drug Discovery Assays Market Share by Country (2020-2031)
 Figure 23. United States Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Drug Discovery Assays Market Share by Country (2020-2031)
 Figure 27. Germany Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Drug Discovery Assays Market Share by Region (2020-2031)
 Figure 35. China Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Drug Discovery Assays Market Share by Country (2020-2031)
 Figure 43. Mexico Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Drug Discovery Assays Market Share by Country (2020-2031)
 Figure 47. Turkey Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Drug Discovery Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 51. Danaher Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 52. Becton Dickinson Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 53. GE Healthcare Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 54. Merck Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 55. Lonza Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 56. PerkinElmer, Inc. Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 57. Charles River Laboratories, Inc. Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 58. Cell Signaling Technologies Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 59. Cisbio Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 60. Cell Biolabs, Inc. Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 61. Promega Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 62. Pfizer Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 63. GSK Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 64. Agilent Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 65. Eli Lilly and Company Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 66. Roche Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 67. Bayer Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 68. Abbott Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 69. AstraZeneca Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 70. Shimadzu Revenue Growth Rate in Drug Discovery Assays Business (2020-2025)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart